Joel Schneider
Algemeen Directeur bij Carbon Biosciences, Inc.
Actieve functies van Joel Schneider
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Carbon Biosciences, Inc.
 Carbon Biosciences, Inc. Medical/Nursing ServicesHealth Services Carbon Biosciences, Inc. is a biotech company that is based in Boston, MA. The company is focused on expanding the therapeutic potential of gene therapy through its proprietary platform which leverages novel parvoviruses that have been pressure tested by nature to target specific tissues and carry a larger cargo with minimal neutralizing immunity and the potential to re-dose. The company is working to expand the gene therapy toolbox for the treatment of the world's most devastating and difficult to treat diseases. Carbon was founded by Longwood Fund and gene therapy pioneers, John F. Engelhardt, Ph.D., and Robert M. Kotin, Ph.D. | Algemeen Directeur | - | - |
| President | - | - |
Loopbaan van Joel Schneider
Eerdere bekende functies van Joel Schneider
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SOLID BIOSCIENCES INC. | Directeur/Bestuurslid | 01-03-2015 | 01-01-2017 |
| Operationeel Directeur | 02-03-2021 | 27-05-2022 | |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2017 | 02-03-2021 | |
| Corporate Officer/Principal | 01-03-2014 | 01-03-2015 |
Opleiding van Joel Schneider
| Brandeis University | Undergraduate Degree |
| Rutgers State University of New Jersey | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 2 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SOLID BIOSCIENCES INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Carbon Biosciences, Inc.
Carbon Biosciences, Inc. Medical/Nursing ServicesHealth Services Carbon Biosciences, Inc. is a biotech company that is based in Boston, MA. The company is focused on expanding the therapeutic potential of gene therapy through its proprietary platform which leverages novel parvoviruses that have been pressure tested by nature to target specific tissues and carry a larger cargo with minimal neutralizing immunity and the potential to re-dose. The company is working to expand the gene therapy toolbox for the treatment of the world's most devastating and difficult to treat diseases. Carbon was founded by Longwood Fund and gene therapy pioneers, John F. Engelhardt, Ph.D., and Robert M. Kotin, Ph.D. | Health Services |
- Beurs
- Insiders
- Joel Schneider
- Ervaring
